Literature DB >> 15762039

Circadian blood pressure profile in patients with Cushing's syndrome before and after treatment.

S Zacharieva1, M Orbetzova, A Stoynev, R Shigarminova, M Yaneva, K Kalinov, E Nachev, A Elenkova.   

Abstract

The aim of the study was to evaluate the circadian blood pressure (BP) profiles in patients with two forms of Cushing's syndrome, and to compare them to those in patients with essential hypertension. The study included 100 patients with Cushing's syndrome (80 with pituitary adenomas and 20 with adrenal adenomas) and 40 with essential hypertension. Twenty-four-h ambulatory BP monitoring was performed before and after therapy. All 3 groups had similar office-, 24-h-, awake-, and sleep BP mean values. The awake-sleep differences between the patients with two forms of Cushing's syndrome were similar. The night-time BP decline in the patients with Cushing's disease, as well as in those with adrenal adenomas, was significantly lower than that in the patients with essential hypertension. In the patients with both forms of Cushing's syndrome, there was a highly significant decline in the office and ambulatory BP levels after the treatment, and the awake-sleep systolic BP difference became significantly higher. The night-time diastolic BP decline was significantly higher after treatment in patients with adrenal adenomas and not-significantly higher in patients with Cushing's disease. In the patients with Cushing's disease, the duration of hypertension was greater, and lower percentage of normalized BP after treatment was observed in comparison with the patients with adrenal adenomas. The significant negative correlation between duration of the disease and extent of the night-time BP decline suggests that the 'non-dipping' profile is related not only to hypercortisolism itself but also to the severity of hypertension and duration of the disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15762039     DOI: 10.1007/BF03347534

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  29 in total

Review 1.  What are the influences of salt, potassium, the sympathetic nervous system, and the renin-angiotensin system on the circadian variation in blood pressure?

Authors:  D A Sica
Journal:  Blood Press Monit       Date:  1999       Impact factor: 1.444

Review 2.  Ambulatory blood pressure monitoring in the management of hypertension.

Authors:  Eoin O'Brien
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

3.  24-hour profiles of blood pressure and heart rate in Cushing's syndrome. Evidence for differential control of cardiovascular variables by glucocorticoids.

Authors:  M Panarelli; M Terzolo; A Piovesan; G Osella; P Paccotti; G Pinna; A Angeli
Journal:  Ann Ital Med Int       Date:  1990 Jan-Mar

Review 4.  Circadian blood pressure variations under different pathophysiological conditions.

Authors:  Y Imai; K Abe; M Munakata; H Sakuma; J Hashimoto; K Imai; H Sekino; K Yoshinaga
Journal:  J Hypertens Suppl       Date:  1990-12

5.  Role of corticosteroids in the diurnal rhythm of blood pressure.

Authors:  S G Jyothinagaram; P Neary; D M Watson; I M McGinley; P L Padfield
Journal:  J Hypertens Suppl       Date:  1989-12

6.  24-hour profiles of blood pressure and heart rate in Cushing's syndrome: relationship between cortisol and cardiovascular rhythmicities.

Authors:  A Piovesan; M Panarelli; M Terzolo; G Osella; C Matrella; P Paccotti; A Angeli
Journal:  Chronobiol Int       Date:  1990       Impact factor: 2.877

7.  Daily blood pressure profile in Cushing's syndrome before and after surgery.

Authors:  A Kreze; M Mikulecky
Journal:  Braz J Med Biol Res       Date:  1999-10       Impact factor: 2.590

8.  Exogenous glucocorticoid eliminates or reverses circadian blood pressure variations.

Authors:  Y Imai; K Abe; S Sasaki; N Minami; M Munakata; M Nihei; H Sekino; K Yoshinaga
Journal:  J Hypertens       Date:  1989-02       Impact factor: 4.844

9.  Nocturnal blood pressure in normotensive subjects and those with white coat, primary, and secondary hypertension.

Authors:  M Middeke; J Schrader
Journal:  BMJ       Date:  1994-03-05

10.  Prognostic value of ambulatory blood pressure measurements: further analyses.

Authors:  D Perloff; M Sokolow; R M Cowan; R P Juster
Journal:  J Hypertens Suppl       Date:  1989-05
View more
  8 in total

1.  Knockout of the vascular endothelial glucocorticoid receptor abrogates dexamethasone-induced hypertension.

Authors:  Julie E Goodwin; Junhui Zhang; David Gonzalez; Sebastian Albinsson; David S Geller
Journal:  J Hypertens       Date:  2011-07       Impact factor: 4.844

2.  A lack of day-by-day variability in blood pressure in a Cushing's disease patient.

Authors:  K Eguchi; H Kurita; E Matsumoto; M Hashimoto; K Kario
Journal:  J Hum Hypertens       Date:  2017-03-23       Impact factor: 3.012

3.  Cushing's syndrome: all variants, detection, and treatment.

Authors:  Susmeeta T Sharma; Lynnette K Nieman
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

4.  Left ventricular geometry and 24-h blood pressure profile in Cushing's syndrome.

Authors:  Eleonora Avenatti; Andrea Rebellato; Andrea Iannaccone; Marialberta Battocchio; Francesca Dassie; Franco Veglio; Alberto Milan; Francesco Fallo
Journal:  Endocrine       Date:  2016-05-14       Impact factor: 3.633

5.  Steroid withdrawal improves blood pressure control and nocturnal dipping in pediatric renal transplant recipients: analysis of a prospective, randomized, controlled trial.

Authors:  Britta Höcker; Lutz T Weber; Ulrike John; Jens Drube; Henry Fehrenbach; Günter Klaus; Martin Pohl; Tomáš Seeman; Alexander Fichtner; Elke Wühl; Burkhard Tönshoff
Journal:  Pediatr Nephrol       Date:  2018-09-04       Impact factor: 3.714

Review 6.  Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.

Authors:  G Arnaldi; T Mancini; G Tirabassi; L Trementino; M Boscaro
Journal:  J Endocrinol Invest       Date:  2012-04       Impact factor: 4.256

7.  A critical role for vascular smooth muscle in acute glucocorticoid-induced hypertension.

Authors:  Julie E Goodwin; Junhui Zhang; David S Geller
Journal:  J Am Soc Nephrol       Date:  2008-04-23       Impact factor: 10.121

Review 8.  The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.

Authors:  Andrea M Isidori; Chiara Graziadio; Rosa Maria Paragliola; Alessia Cozzolino; Alberto G Ambrogio; Annamaria Colao; Salvatore M Corsello; Rosario Pivonello
Journal:  J Hypertens       Date:  2015-01       Impact factor: 4.844

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.